GlassScriptPhysician profile
Clint A Howe
NPI 1306437694
$1,806.54
in general payments reported to CMS, 2019-2025
17 companies · $1,586 in 2025
The $1,586 reported for 2025 was more than what 93% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $221 · 2025: $1,586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,807.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,806.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $355.50 | 2025 | Amvuttra |
| United Therapeutics Corporation | $351.96 | 2024-2025 | Tyvaso, Remodulin, Orenitram |
| Actelion Pharmaceuticals US, INC. | $300.33 | 2025 | Uptravi, Opsumit, Opsynvi |
| Astrazeneca Pharmaceuticals LP | $158.54 | 2025 | Wainua, Farxiga |
| Merck Sharp & Dohme LLC | $154.02 | 2024-2025 | Verquvo, Winrevair, Capvaxive |
| Bridgebio Pharma, INC. | $107.84 | 2025 | Attruby |
| Abiomed | $93.80 | 2025 | |
| Baxter Healthcare | $93.32 | 2025 | Starling System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.45 | 2024-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $30.06 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.69 | 2025 | Lifevest |
| Liquidia Technologies, INC. | $18.66 | 2025 | Yutrepia |
| Lexicon Pharmaceuticals, INC. | $16.37 | 2024 | |
| Novo Nordisk INC | $14.48 | 2025 | Wegovy |
| Lilly USA, LLC | $14.44 | 2025 | Zepbound |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $14.22 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.86 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clint Howe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.